Monopar Therapeutics
MNPR
MNPR
12 hedge funds and large institutions have $533K invested in Monopar Therapeutics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13K | |
| 2 | +$2.93K | |
| 3 | +$103 | |
| 4 |
Morgan Stanley
New York
|
+$12 |